BiotechTube
Home/Orizuru Therapeutics/Kenji Nonaka
KN

Kenji Nonaka

Representative Director

Orizuru Therapeutics

Therapeutic Areas

Metabolic DisordersEndocrinology

Orizuru Therapeutics Pipeline

DrugIndicationPhase
OZTx-410Type 1 DiabetesPhase 1